source
- Lisata acquires Marea Therapeutics, securing $225M financing to advance two mid-stage drugsLisata Therapeutics completed a stock-for-stock acquisition of biotech startup Marea Therapeutics. The transaction includes a $225 million financing round led by existing backers such as Forbion,…
- ARPA-H launches SPECTRA program to advance autism diagnosis and precision careARPA-H announced the launch of the Systems for Phenotypic Evaluation, Clinical Trajectories, Response, and Agency (SPECTRA) program, a new effort aimed at transforming autism diagnosis and precisio…